Innovate UK Biomedical Catalyst Accelerator - Future Medicines
LYVA Labs, in partnership with Innovate UK and a consortium of internationally recognised scientific, technical, and commercial experts, is proud to launch the Innovate UK Biomedical Catalyst Accelerator - Future Medicines.
The Biomedical Catalyst is Innovate UK’s flagship grant funding mechanism, designed to accelerate innovation and help UK companies bring products to market more efficiently.
Part of the Innovate UK Biomedical Catalyst, Accelerators help SMEs, spinouts, and academic innovators develop and test innovative health and care solutions across therapeutics, medical devices, diagnostics, and digital health. Through thematic Accelerators, participants gain tailored support to refine their ideas, explore market viability, and prepare for clinical or commercial validation.
Sectors in-scope:
The development, discovery or manufacturing of a broad range of next-generation medical treatments, technologies, products, processes, or services to address increasingly complex diseases, usually leveraging advanced scientific approaches for more targeted, effective therapies tailored to individual patient needs.
Examples include (but are not restricted to) the fields below. We are particularly interested in applicants working in Radiopharmaceuticals.